This outbreak, the first in a decade of the less common Sudan strain, is a chance for clinical trials of the three vaccines donated by the U.S.-based Sabin Vaccine Institute, University of Oxford and Merck.
New data from the Centers for Disease Control and Prevention (CDC) show the bivalent COVID-19 booster shot was effective at reducing the risk of hospitalization and emergency room visits by at least 50 percent.
Recent Comments